论文信息 - Propranolol to treat infantile hemangioma (IH) in patients with congenital heart disease. - 字舞流文

Propranolol to treat infantile hemangioma (IH) in patients with congenital heart disease.

Hoon-Soo Kim | H. Ko | M. Kim | Byung-Soo Kim | H. You

[1] R. Roenigk,et al. Leiomyosarcoma of the skin: clinical, histopathologic, and prognostic factors that influence outcomes. , 2014, Journal of the American Academy of Dermatology.

[2] K. Holland,et al. Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference , 2013, Pediatrics.

[3] I. Betlloch-Más,et al. Outpatient Treatment of Infantile Hemangiomas With Propranolol: A Prospective Study , 2012 .

[4] I. Betlloch-Mas,et al. Tratamiento de hemangiomas infantiles con propranolol en régimen de control ambulatorio. Estudio prospectivo , 2012 .

[5] J. Kleber,et al. Propranolol Therapy in 55 Infants with Infantile Hemangioma: Dosage, Duration, Adverse Effects, and Outcome , 2011, Pediatric dermatology.

[6] M. Raphaël,et al. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants. , 2011, Journal of the American Academy of Dermatology.

[7] L. Difrancesco,et al. Superficial leiomyosarcoma: a clinicopathologic review and update , 2010, Journal of cutaneous pathology.

[8] N. Sikka,et al. Are 1-2 tablets dangerous? Beta-blocker exposure in toddlers. , 2004, The Journal of emergency medicine.